Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
10
×
national blog main
vc
10
×
startups
biotech
national top stories
san diego blog main
san francisco blog main
deals
medical devices
new york blog main
san diego top stories
wisconsin blog main
wisconsin top stories
boston blog main
boston top stories
new york top stories
san francisco top stories
venture capital
fda
financing
ipo
raleigh-durham blog main
raleigh-durham top stories
wisconsin
biogen
boulder/denver blog main
boulder/denver top stories
cancer
cybersecurity
detroit blog main
detroit top stories
digital health
drugs
funding
gene therapy
indiana blog main
indiana top stories
laura shawver
national
What
new
10
×
medicines
startup
developing
drugs
million
raises
advance
bio
biotech
cash
device
diseases
economic
funding
investors
ipo
life
nearly
roundup
technology
therapeutics
today
venture
wi
years
activity
aiming
aims
allogene
ambys
animal
animals
app
approach
approvals
asto
based
big
bigger
Language
unset
Current search:
new
×
" life sciences "
×
vc
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Madison Startup Asto CT Raises $1.1M for Large Animal Imaging Device
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs